NCT02490085 Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy Status COMPLETED Phase PHASE2
NCT02488616 Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes Status WITHDRAWN Phase PHASE2
NCT02486341 Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin Status COMPLETED Phase NA
NCT02432976 Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients Status COMPLETED Phase PHASE2/PHASE3
NCT02429258 Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin Status COMPLETED Phase PHASE4
NCT02417090 Late Metabolic Effects of Metformin Therapy in Gestational Diabetes Status COMPLETED Phase N/A
NCT02407899 Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes Status COMPLETED Phase PHASE4
NCT02307695 The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes Status UNKNOWN Phase PHASE4
NCT02305069 Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle Status COMPLETED Phase NA
NCT02304211 Intra-Arterial Microdosing: Proof-of-Concept in Humans Status COMPLETED Phase EARLY_PHASE1
NCT02284009 Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02234440 Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance Status COMPLETED Phase NA
NCT02220920 Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT02176681 A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM Status COMPLETED Phase PHASE4
NCT02161055 Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury Status UNKNOWN Phase PHASE4
NCT02154347 Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT02081599 Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4